Thomas Argentieri, Ph.D.

Vice President of Business Development & Alliance Management - Partner

Dr. Thomas Argentieri is a Pharma and Biotech Executive with over 30 years of experience in academic, Pharma and Biotech R&D. Dr. Argentieri received his Ph.D. in pharmacology from the New Jersey Medical School (Rutgers University) focusing on ion channel biophysics and received post-doctoral training at the University of Pennsylvania. He spent several years as a research assistant professor at the University of Pennsylvania's department of medicine studying mechanisms of cardiac arrhythmias. From there Dr. Argentieri was Section Head at Berlex Pharmaceuticals, helping to build and lead their antiarrhythmic and antihypertensive drug discovery efforts putting 2 drugs into the clinic. Seven years later he was recruited by Wyeth Pharmaceuticals to direct their Urologic Disorders division where he oversaw the development of novel ion channel modulators and beta-3 adrenergic receptor agonists for the treatment of overactive bladder. During this period he authored over 70 peer-reviewed manuscripts, review articles, and book chapters, and was awarded 10 patents. After over 20 years in R&D, he transitioned into business development performing in-licensing and out-licensing activities for the pharmaceutical and Biotech industries and conducted numerous deals on both the buy and sell-side. Dr. Argentieri is the owner and founder of BioSense Solutions, a company that provides scientific evaluation, market research, licensing, and business development expertise to the pharmaceutical and biotech industries. He currently serves on the editorial boards of the Journal of Pharmacology and Experimental Therapeutics (JPET) and the Open Pharmacology Journal.